Bill Details
View committees (2)
View cosponsors (9)
- Rep. Kennedy, Timothy M. [D-New York-26]
- Rep. Griffith, H. Morgan [R-Virginia-9]
- Rep. LaHood, Darin [R-Illinois-16]
- Rep. Soto, Darren [D-Florida-9]
- Rep. Wasserman Schultz, Debbie [D-Florida-25]
- Rep. Bresnahan, Robert P. [R-Pennsylvania-8]
- Rep. Neguse, Joe [D-Colorado-2]
- Rep. Tonko, Paul [D-New York-20]
- Rep. Lieu, Ted [D-California-36]
AI Summary This summary was generated by AI from the bill text. AI can get information wrong.
This bill would let Medicare cover more types of lung cancer screening tests as preventive care. Right now, Medicare covers certain lung cancer screenings, and this bill would give the health secretary the power to approve additional screening tests that are cleared or approved by the Food and Drug Administration. The goal is to make it easier for people at risk of lung cancer to get screened earlier, which can help find the disease sooner and improve treatment results.
- Medicare could cover new lung cancer screening tests beyond the ones already approved under current rules.
- These tests would have to be cleared or approved by the Food and Drug Administration and used for people the health secretary считает appropriate.
- The health secretary would decide how often the tests can be covered and what Medicare will pay, while consulting with relevant expert groups.
- Coverage decisions would still go through Medicare’s normal national review process, and the changes would take effect as soon as the bill becomes law.
Official Summaries
Lung Cancer Screening and Prevention Act of 2025
This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the Food and Drug Administration, regardless of whether they are recommended by the United States Preventive Services Task Force. The Centers for Medicare & Medicaid Services must set coverage and payment limits for such tests. (Currently, Medicare covers screening tests for the early detection of lung cancer if they are recommended by the task force.)
Current Full Text
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1406 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 1406
To amend title XVIII of the Social Security Act to authorize the
coverage of additional lung cancer screening tests under the Medicare
program.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 18, 2025
Mr. Buchanan (for himself, Mr. Kennedy of New York, Mr. Griffith, Mr.
LaHood, Mr. Soto, and Ms. Wasserman Schultz) introduced the following
bill; which was referred to the Committee on Energy and Commerce, and
in addition to the Committee on Ways and Means, for a period to be
subsequently determined by the Speaker, in each case for consideration
of such provisions as fall within the jurisdiction of the committee
concerned
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to authorize the
coverage of additional lung cancer screening tests under the Medicare
program.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Lung Cancer Screening and Prevention
Act of 2025''.
SEC. 2. AUTHORITY TO EXPAND COVERAGE OF TESTS FOR LUNG CANCER SCREENING
UNDER THE MEDICARE PROGRAM.
(a) In General.--Section 1834(n) of the Social Security Act (42
U.S.C. 1395m(n)) is amended--
(1) by redesignating subparagraphs (A) and (B) of paragraph
(1) as clauses (i) and (ii), respectively, with appropriate
indentation;
(2) by redesignating paragraphs (1) and (2) as
subparagraphs (A) and (B), respectively, with appropriate
indentation;
(3) by striking ``Notwithstanding any other provision of
this title'' and inserting:
``(1) In general.--Notwithstanding any other provision of
this title and subject to paragraph (2)''; and
(4) by adding at the end the following new paragraph:
``(2) Authority to cover new lung cancer screening tests as
preventive services.--
``(A) In general.--Notwithstanding paragraph (1),
in addition to preventive services consisting of
screening tests for the early detection of lung cancer
covered under this part pursuant to national coverage
determination 210.14, the Secretary may provide for
coverage under this part of other lung cancer screening
tests that are cleared or approved by the Food and Drug
Administration as preventive services when furnished to
appropriate individuals (as determined by the
Secretary), with such frequency and payment limits as
the Secretary determines appropriate in consultation
with appropriate organizations.
``(B) Use of national coverage determination
process.--
``(i) In general.--Coverage of other lung
cancer screening tests under subparagraph (A)
shall be determined using the process for
making national coverage determinations (as
defined in section 1869(f)(1)(B)), except that
there shall be no requirement for a
determination under section 1861(ddd)(3)(B)
with respect to such test under such process.
``(ii) Rule of construction.--Nothing in
clause (i) shall be construed as preventing the
Secretary from considering recommendations made
by entities with expertise in preventive
services, including entities convened by the
Secretary or the Director of the Agency for
Healthcare Research and Quality, with respect
to other lung cancer screening tests described
in subparagraph (A).''.
(b) Effective Date.--The amendments made by subsection (a) shall
take effect on the date of the enactment of this Act, and apply with
respect to coverage of preventive services under Part B of title XVIII
of the Social Security Act (42 U.S.C. 1395j et seq.) on or after such
date.
<all>